Health Insurance Reform: New Respite for Pharmaceutical Industry
TL;DR
AI-generated
A planned health insurance reform proposes to ease savings contributions from the pharmaceutical industry. Instead of a flexible, higher discount on drug prices, a fixed 15.5 percent rebate was intended, which could now partially fall back to seven percent. This would result in additional costs for statutory health insurers.
Source: taz.de
Discussion
Log in to join the discussion.
No comments yet. Be the first!